Delivery Order SPE2DB20D3304-SPE2DB25FW8S5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $15,285.96 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.46 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 10, 2025, with a ceiling value of $3,318.38. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded with no set-aside designation. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count packages) on September 4, 2025, with a ceiling value of $1,565.46. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.01 to AmerisourceBergen Drug Corp on August 15, 2025, for Yuvafem 10 micrograms vaginal insert (18 units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction within the federal pharmaceutical supply chain. The contract is set to complete by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8S5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,116.84 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, which was not set-aside, represents a routine pharmaceutical procurement under the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support for military healthcare programs. The parent indefinite delivery contract enables the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The award reflects the vendor's established capability to meet federal procurement requirements through competitive processes and demonstrates the company's role in supporting military medical readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/22/25 |